Commentary · 21 Feb 2026
Conference abstractPublished 21 Oct 2013
Ex vivo and in vivo evaluation of Impossible tochopherol and tocopherol acetate formulations
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The objectives of this study were: a) preparation of the of tocopherol (T) and tocopherol acetate (TA) in different local formulations, self-emulsified drug delivery systems (SEDDS), gel and monophasic liquid systems; b) evaluation of ex vivo and in vivo transdermal permeation of T/TA from the promising formulations. Analysis of T/TA was performed by a validated HPLC method using UV detector. The relevant physicochemical properties of the tested formulations were assessed. The ex vivo, performed in vertical Franz diffusion cells, and in vivo permeation through neonatal rat skin was evaluated. Design of Experiment (DOE) was carried out to optimize the formulation factors. The permeation of T from SEDDS, gel and emulsion formulations was very poor (0.001-0.013%). The results of DEO indicated a good agreement between actual and predicted values. The highest permeation (0.07%) was observed from monophasic liquid formulations, with the highest (5%) dimethyl sulfuxide (DMSO), medium (0.5%) tocopheryl polyethylene glycols (TPGs), and lower (0.5%) T concentration. The in vivo results demonstrated higher retention properties of the stratum corneum layer, compared to the subcutaneous tissues; 1377 and 1.13 μg/g , respectively. Increasing T concentration from 4.8 to 9.5% did not increase the amount permeated and %-retained of T. The %-retained values were close to each other for both T concentrations (4.8 and 9.5%); 16.33 and 17.34%, respectively. Simple solutions of T in presence of DMSO and TPGs are more promising systems; compared to, SEDDS, gel, emulsion or oleaginous systems.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Aly H. Nada”
